Literature DB >> 13354693

Toxoplasmic uveitis; treatment with pyrimethamine and sulfadiazine.

V A BEUERMAN, C J BURNHAM.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapeutic use; SULFONAMIDES/therapeutic use; TOXOPLASMOSIS/manifestations; UVEITIS/etiology and pathogenesis

Mesh：

Substances：

Year:  1956        PMID： 13354693

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  6 in total

1.  [Clinical study of ocular toxoplasmosis].

Authors:  R WEEKERS; M BONNET DE RUDDER; J BASSLEER
Journal:  Doc Ophthalmol       Date:  1960       Impact factor: 2.379

2.  Toxoplasmic retinochoroiditis.

Authors:  J V CASSADY
Journal:  Trans Am Ophthalmol Soc       Date:  1960

3.  [Contribution to acquired ocular toxoplasmosis].

Authors:  F MUELLER
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1959

Review 4.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

Review 5.  Drug repurposing for the treatment of staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Waleed Younis; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 6.  Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.

Authors:  Ruben R Ben-Harari; Elizabeth Goodwin; Julio Casoy
Journal:  Drugs R D       Date:  2017-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.